Picture of Terrascend logo

TSND — Terrascend News Story

0.000.00%
ca flag iconLast trade - 00:00
Consumer DefensivesSpeculativeSmall CapContrarian

Brief: MediPharm Labs And TerrAscend Enter Major Private Label Concentrate Supply Agreement With Potential Value Up To $192 Mln

Sept 25 (Reuters) - MediPharm Labs Corp  LABS.TO :
    * MEDIPHARM LABS AND TERRASCEND ENTER MAJOR PRIVATE LABEL
CONCENTRATE SUPPLY AGREEMENT WITH POTENTIAL VALUE UP TO $192
MILLION
    * MEDIPHARM LABS - WILL SUPPLY TERRASCEND WITH ABOUT $27
MILLION
OF PRIVATE LABEL CANNABIS DISTILLATE, OVER 24-MONTHS COMMENCING
SEPT
    * MEDIPHARM LABS CORP - MULTI-YEAR SUPPLY AGREEMENT TO
SUPPORT
TERRASCEND'S ROLL OUT OF CANADIAN CANNABIS 2.0 DERIVATIVE
PRODUCTS
    * MEDIPHARM LABS CORP - WILL HAVE OPTION TO PURCHASE UP TO
AN
ADDITIONAL $105 MILLION OF CANNABIS CONCENTRATE OVER SAME
PERIOD, IN DEAL

Source text for Eikon:  ID:nGNX3drNq8 
Further company coverage:  LABS.TO 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Terrascend

See all news